ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Amplia Therapeutics Limited

Amplia Therapeutics Limited (ATX)

0.115
-0.005
(-4.17%)
終了 6月7日 3:00PM

Amplia Therapeutics Limited (ATX) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
0.115
( -4.17% )
買値
0.115
売値
0.12
出来高
947,854
0.115 日の範囲 0.12
0.05 52 週間の範囲 0.425
時価総額
前日終値
0.12
始値
0.12
時刻
1
@
0.12
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
AUD 4,488,507
発行済株式数
513,312,014
配当利回り
PER
-8.23
1 株当たり利益 (EPS)
-0.02
歳入
5.49M
純利益
-7.71M

Amplia Therapeutics Limited について

Amplia Therapeutics Limited, a clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its product pipeline comprises Narmafotinib (AMP945), an inhibitor of FAK, which is in 1b/2a clinical trial for pancreati... Amplia Therapeutics Limited, a clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its product pipeline comprises Narmafotinib (AMP945), an inhibitor of FAK, which is in 1b/2a clinical trial for pancreatic cancer; and treatment of idiopathic pulmonary fibrosis, as well as ovarian cancer. It also develops AMP886 for application in oncology and chronic fibrosis indications. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Melbourne, Australia
設立
2026
Amplia Therapeutics Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker ATX. The last closing price for Amplia Therapeutics was AUD0.12. Over the last year, Amplia Therapeutics shares have traded in a share price range of AUD 0.05 to AUD 0.425.

Amplia Therapeutics currently has 513,312,014 shares in issue. The market capitalisation of Amplia Therapeutics is AUD59.03 million. Amplia Therapeutics has a price to earnings ratio (PE ratio) of -8.23.

ATX 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.025-17.85714285710.140.140.11513966840.12774816DE
4-0.025-17.85714285710.140.170.1159290660.13648375DE
12000.1150.2750.10549118900.20415509DE
26-0.015-11.53846153850.130.2750.125752960.19608743DE
520.064125.4901960780.0510.4250.0534081230.2041563DE
1560.0335.29411764710.0850.4250.04916330580.17566941DE
260-0.135-540.250.4250.04910410180.17415994DE

ATX - Frequently Asked Questions (FAQ)

What is the current Amplia Therapeutics Limited share price?
The current share price of Amplia Therapeutics Limited is AUD 0.115
How many Amplia Therapeutics Limited shares are in issue?
Amplia Therapeutics Limited has 513,312,014 shares in issue
What is the market cap of Amplia Therapeutics Limited?
The market capitalisation of Amplia Therapeutics Limited is AUD 59.03M
What is the 1 year trading range for Amplia Therapeutics Limited share price?
Amplia Therapeutics Limited has traded in the range of AUD 0.05 to AUD 0.425 during the past year
What is the PE ratio of Amplia Therapeutics Limited?
The price to earnings ratio of Amplia Therapeutics Limited is -8.23
What is the cash to sales ratio of Amplia Therapeutics Limited?
The cash to sales ratio of Amplia Therapeutics Limited is 12.62
What is the registered address of Amplia Therapeutics Limited?
The registered address for Amplia Therapeutics Limited is 90 William Street, Melbourne, Victoria, 3000
What is the Amplia Therapeutics Limited website address?
The website address for Amplia Therapeutics Limited is www.ampliatx.com
Which industry sector does Amplia Therapeutics Limited operate in?
Amplia Therapeutics Limited operates in the Biotechnology & Life Sciences sector

ATX 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード